Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial.

Semple MG, Donohue C, Price L, Cooper R, Vaughan C, Moitt T, Finnetty L, Ritson PC, Osaghae B, Allen E, Fowler C, Agbeko RS, Brincat E, Cassidy JV, Davies PE, Davis PJ, Day E, Kanaris C, Lampariello S, Levin R, Lo TM, Morris KP, Osman A, Playfor SD, Richardson J, Sefton G, Sundararajan S, Weitz J, Wherton-Whitehurst A, Deja E, Woolfall K, Madsen J, Postle AD, Barker C, Gamble C, Clark HW, Pappachan J, Thorburn K, Peak M, McNamara PS, Turner MA, Jones AP, BESS Investigators.

Open source

DOI
10.1016/s2213-2600(26)00008-1
Published
2026-03-21
Container
Lancet Respir Med
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-26-00008-1,
  title = {Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial.},
  author = {Semple MG and  Donohue C and  Price L and  Cooper R and  Vaughan C and  Moitt T and  Finnetty L and  Ritson PC and  Osaghae B and  Allen E and  Fowler C and  Agbeko RS and  Brincat E and  Cassidy JV and  Davies PE and  Davis PJ and  Day E and  Kanaris C and  Lampariello S and  Levin R and  Lo TM and  Morris KP and  Osman A and  Playfor SD and  Richardson J and  Sefton G and  Sundararajan S and  Weitz J and  Wherton-Whitehurst A and  Deja E and  Woolfall K and  Madsen J and  Postle AD and  Barker C and  Gamble C and  Clark HW and  Pappachan J and  Thorburn K and  Peak M and  McNamara PS and  Turner MA and  Jones AP and  BESS Investigators.},
  year = {2026},
  journal = {Lancet Respir Med},
  doi = {10.1016/s2213-2600(26)00008-1},
  url = {https://doi.org/10.1016/s2213-2600(26)00008-1}
}

RIS

TY  - JOUR
TI  - Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial.
AU  - Semple MG
AU  -  Donohue C
AU  -  Price L
AU  -  Cooper R
AU  -  Vaughan C
AU  -  Moitt T
AU  -  Finnetty L
AU  -  Ritson PC
AU  -  Osaghae B
AU  -  Allen E
AU  -  Fowler C
AU  -  Agbeko RS
AU  -  Brincat E
AU  -  Cassidy JV
AU  -  Davies PE
AU  -  Davis PJ
AU  -  Day E
AU  -  Kanaris C
AU  -  Lampariello S
AU  -  Levin R
AU  -  Lo TM
AU  -  Morris KP
AU  -  Osman A
AU  -  Playfor SD
AU  -  Richardson J
AU  -  Sefton G
AU  -  Sundararajan S
AU  -  Weitz J
AU  -  Wherton-Whitehurst A
AU  -  Deja E
AU  -  Woolfall K
AU  -  Madsen J
AU  -  Postle AD
AU  -  Barker C
AU  -  Gamble C
AU  -  Clark HW
AU  -  Pappachan J
AU  -  Thorburn K
AU  -  Peak M
AU  -  McNamara PS
AU  -  Turner MA
AU  -  Jones AP
AU  -  BESS Investigators.
PY  - 2026
JO  - Lancet Respir Med
DO  - 10.1016/s2213-2600(26)00008-1
UR  - https://doi.org/10.1016/s2213-2600(26)00008-1
ER  - 

APA

MG, S., C, D., L, P., R, C., C, V., T, M., L, F., PC, R., B, O., E, A., C, F., RS, A., E, B., JV, C., PE, D., PJ, D., E, D., C, K., S, L., R, L., TM, L., KP, M., A, O., SD, P., J, R., G, S., S, S., J, W., A, W., E, D., K, W., J, M., AD, P., C, B., C, G., HW, C., J, P., K, T., M, P., PS, M., MA, T., AP, J., & Investigators., B. (2026). Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial.. Lancet Respir Med. https://doi.org/10.1016/s2213-2600(26)00008-1

Source records